Skip to content

Clinical trials

Phase 4 Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 4 Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20093
20111
20121
20131
20151
20161
20181
20202
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7
Completed4
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shenzhen SiBiono GeneTech Co.,Ltd3
AstraZeneca1
Chongqing University Cancer Hospital1
Cttq1
Jiangsu Famous Medical Technology Co., Ltd.1
Novartis Pharmaceuticals1
Pfizer1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shandong Cancer Hospital and Institute1
Shandong Luye Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms14
Carcinoma, Non-Small-Cell Lung2
Ovarian Neoplasms2
Vomiting2
Adenoma1
Breast Neoplasms1
Bronchial Neoplasms1
Carcinoma1
Carcinoma, Bronchogenic1
Esophageal Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.